Medivolve Inc. (OTCPK:COPR.F) signed a binding agreement to acquire Marbella Pharmacy for $0.5 million on May 17, 2021. As part of the consideration Medivolve Inc. will pay a cash payment of $0.2 million payable 60 days following the closing, a working capital cash payment of $0.07 million payable 75 days post closing and will issue 2 million Medivolve common shares. No finder fees are payable and no change of control of Medivolve Inc. will result from the transaction. The completion of the transaction is subject to customary closing conditions and NEO Stock Exchange approval. As announced on June 17, 2021, the Pharmacy became CalVax approved and participates in the California COVID-19 Vaccination initiative, administering vaccines through its retail locations, along with partner clinics. Medivolve Inc. (OTCPK:COPR.F) completed the acquisition of Marbella Pharmacy on August 13, 2021.